New Stock Options Granted
December 03 2013 - 8:00AM
Access Wire
CALIFORNIA NANOTECHNOLOGIES ISSUES STOCK
OPTIONS
CALIFORNIA NANOTECHNOLOGIES CORP.
CNO-TSX VENTURE
CERRITOS, CALIFORNIA, //Accesswire// December 3, 2013 -
California Nanotechnologies Corp. is pleased to announce the
appointment of Mr. Christopher Melnyk as CEO of the
Corporation. Mr. Melnyk has been Vice President for the last
3 years and as such has been instrumental in driving the Company
forward. Mr. Andy Bengis will be taking on the role of
Interim CFO. Mr. Bengis has undertaken most of the accounting
functions of California Nanotechnologies for several years and as a
result is well prepared to undertake this new role. Both of
these appointments are effective December 1, 2013.
The Company would like to thank Mr. Timothy Wang for his
contribution as CFO over the last 6 years. Mr. David Grant
will remain as the Chairman of the Board of Directors while
relinquishing his daily function as CEO.
To encourage the further development of the Company, incentive
stock options have been granted to the following officers and
directors. The options were granted according to the table
below:
|
Name
|
Position
|
Options Granted
|
|
David F. Grant
|
Director
|
300,000
|
|
Christopher Melnyk
|
CEO
|
300,000
|
|
Andrew Bengis
|
Interim CFO
|
100,000
|
|
Donald Kelly
|
Director
|
50,000
|
|
Norman Goodrich
|
Director
|
50,000
|
These options were granted on Dec 3, 2013 and are priced at
$0.05 which is the Minimum Price as defined by the TSX Venture
Corporate Manual. The options were granted pursuant to the
Company’s Stock Option Plan, which received shareholder approval at
the Annual General and Special Meeting held on October 18,
2013. These stock options vest equally over a three year
period, expire after a five years, and are subject to TSX Venture
Exchange requirements.
Except for historical information contained herein this
document contains forward-looking statements. These statements
contain known and unknown risks and uncertainties that may cause
the company’s actual results or outcomes to be materially different
from those anticipated and discussed herein.
For further information, please contact:
Christopher Melnyk, CEO
(562) 991-5335
(562) 926-6913 (fax)
c.melnyk@calnanocorp.com
Neither TSX Venture Exchange nor its Regulation
Services Provider (as that term is defined in policies of the TSX
Venture Exchange) accepts responsibility for the adequacy or
accuracy of this
release.
www.calnanocorp.com
California Nanotechnolog... (TSXV:CNO)
Historical Stock Chart
From Apr 2024 to May 2024
California Nanotechnolog... (TSXV:CNO)
Historical Stock Chart
From May 2023 to May 2024
